Specialists in the fields of allergology, pulmonology, pediatric pulmonology and family medicine have prepared a joint position on the transition of medical aerosols in light of EU environmental regulations.
Experts fully support the efforts of the European Union to protect the environment and improve the quality of life of citizens, but express strong opposition to the potential threat to the availability or complete prevention of access to essential medicines for patients suffering from respiratory diseases who require the use of inhaled medicines, e.g. in the case of asthma or chronic obstructive pulmonary disease (COPD).
The submitted position presents a joint proposal of experts to introduce changes to the proposed regulations.
Full text of the position: https://bit.ly/3Ncdh6J
Latest news
GINA 2025
The 2025 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an
World Asthma Day
In celebration of World Asthma Day 2025, the Global Initiative for Asthma (GINA) has chosen the theme “Make Inhaled Treatments Accessible for ALL”. GINA emphasizes the need
Coalition of Asthma Treatment at the 10th Health Challenges Congress
On 13-14 March, the jubilee edition of the Health Challenges Congress (HCC) took place – one of the key events devoted to the future of
Meeting at the European Parliament
On 5 February 2025, the European Parliament hosted a hybrid meeting entitled “Raising the Standards of Care for COPD in Europe”, organised by the European
